ERBB2 and breast cancer: Bazhabayi et al. (Bazhabayi et al., 2021) report that circGFRA1 was upregulated in HER-2-positive breast cancer cells and tissues, and silencing circGFRA1 inhibited the proliferation of HER-2-positive breast cancer cells while inhibiting their infiltration and metastasis.